Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Dancing as an Alternative to the Traditional Exercising in Older Adults With Cardiac Diseases (1382)

8 settembre 2026 aggiornato da: University College, London

The Effectiveness of Azerbaijani National Dances on Cardiorespiratory Fitness and Quality of Life of Older Adults With Chronic Heart Failure Diagnosis

According to the Global Burden of Disease Study (2017) 64 million people worldwide are living with Heart Failure (HF). Risk factors of HF include age, history of coronary heart disease, atrial fibrillation, hypertension, diabetes mellitus, smoking and low physical activity.

There is clear evidence that regular physical activity can increase life expectancy and improve cognitive function, and delay functional disabilities associated with aging. Physical Activity and exercise training is considered as one of the components cardiovascular disease prevention and rehabilitation program. There is a growing scientific support that cardiac rehabilitation (CR) slows, stabilizes or regresses cardiovascular disease (CVD). In addition, it has been shown that CR programs significantly reduce re-hospitalisation and death from CVDs by up to 25%.

Despite of strong evidence of the positive effects of exercise training in Chronic HF patients, the adherence to the exercise component of CR is still not at the level recommended by the international physical activity guidelines. Patients participating in physical activity programs are faced with several obstacles, such as orthopaedic limitations to exercise, or being severely overweight. Another most common barriers for participating in CR are family and employment obligation, psychological well-being and age ("CR is only for adults"). Participation of older adults in physical exercises programs is highly influenced by their personal interest in activity type, engagement and perceived advantages. The author is also mentioned that engaging in different types of activities or adding new elements to the traditional exercises may increase and maintain individuals' interest and engagement in physical activity. This will improve their commitment t the regular exercise and leading to improved health outcomes.

World Health Organisation defines dance as a type of physical activity and recommends its implementation to develop physical skills, especially in the least active population groups. Scientists highlight the advantages of dancing over traditional strength and balance exercises that are often performed individually, whereas dance is predominantly a group activity.

According to the Ministry of Culture of the Republic Azerbaijan, Azerbaijani traditional dances represent the ancient culture of the country and are popular activity among both young and older people. Azerbaijani dancing has a major social role in bringing people together during celebration of National Holidays and family events.

However, use of traditional dancing in general, and Azerbaijani dances particularly, as an intervention in CR programs has not been well established. Screening of reports published since 2015, revealed only randomized control studies which identified the dance intervention as national/cultural dancing style. All those studies demonstrated positive impact of traditional dancing on the functional capacity and psychological condition of people with chronic diseases.

More research on the use of the cultural dancing as an alternative to traditional exercise programs as a part of CR could provide clearer evidence about the role and effectiveness of traditional dance in CR.

The aim of this research is to investigate the impact of Azerbaijani Cultural Dances on cardiorespiratory fitness and quality of life of patients with chronic HF.

Panoramica dello studio

Tipo di studio

Interventistico

Iscrizione (Stimato)

120

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

      • Baku, Azerbaigian, AZ1102
        • Azerbaijan Sports Academy

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto più anziano

Accetta volontari sani

No

Descrizione

Key Inclusion Criteria:

  • Echocardiography detected ejection fraction - 40-49% to justify the heart failure
  • Age between 65-85.

Exclusion Criteria:

  • Age below 65
  • Ejection fraction less than 40% and higher than 49%
  • Structural changes of the myocardium (aneurysms, scars, valvular diseases).
  • Signs of pleural or pericardial effusions
  • Clinically manifested comorbidities (unstable angina)
  • Uncontrolled Cardiac Arrhythmias

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Prevenzione
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Dancing arm. The intervention will last for 12 weeks, with a twice weekly session lasting 60 min.

Dance sessions will be delivered by the professional dance instructor who trained to work with older adults. Exercise session - by physiotherapist who is trained and has a bachelor's degree in Sport and Exercise Science. Considering that sessions are going to be conducted with one MD and one Nurse on site, 5-7 participants per each session are permitted for the easy observation and help in case of necessity. Only one dance/exercise instructor will attend the session.

Certified MD and nurse will observe the whole session. They both BLS and AED application trained. There is an EAD on site. Lab staff is instructed about contact details of Ambulance and Emergency services. The nearest Ambulance station is in 3 minutes driving distance. Each dancing sessions will consist of three phases: 15 min warm-up, 30 min dance, 15 minutes cooldown period. According to the exercise recommendations in individuals with chronic heart failure, session will consist of aerobic /endurance exercises.

Dance sessions will be delivered by the professional dance instructor who trained to work with older adults. Exercise session - by physiotherapist who is trained and has a bachelor's degree in Sport and Exercise Science.

Considering that sessions are going to be conducted with one MD and one Nurse on site, 5-7 participants per each session are permitted for the easy observation and help in case of necessity. Only one dance/exercise instructor will attend the session.

Certified MD and nurse will observe the whole session. They both BLS and AED application trained. There is an EAD on site.

Each dancing and exercising sessions will consist of three phases: 15 min warm-up, 30 min dance/exercise session, 15 minutes cooldown period.

Exercise sessions are going to be designed based on the 2020 ESC Guidelines on sports cardiology and exercise in pat

Comparatore attivo: Exercising Group

Exercise sessions are going to be designed based on the 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. According to the exercise recommendations in individuals with chronic heart failure, session will consist of aerobic /endurance exercises with low intensity about 40% of VO2 peak. This will continue for about 2 weeks. After 2 weeks the intensity will be gradually increased to 50-65% if tolerated with aiming to reach 70-75% by the end of the 12th week. In addition to the aerobic/endurance training, resistance training exercises will also be added to the structure of the sessions (the intensity level will be kept the same as with aerobic).

Warm-up is going to start with very low intensity aerobic/endurance training. Cool-down is stretching exercises and respiratory exercises (10-15 minutes).

Before and after each session blood pressure, resting HR and oxygen saturation will be measured.

Exercise sessions are going to be designed based on the 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. According to the exercise recommendations in individuals with chronic heart failure, session will consist of aerobic/endurance exercises with low intensity about 40% of VO2 peak. This will continue for about 2 weeks. After 2 weeks the intensity will be gradually increased to 50-65% if tolerated with aiming to reach 70-75% by the end of the 12th week. In addition to the aerobic/endurance training, resistance training exercises will also be added to the structure of the sessions (the intensity level will be kept the same as with aerobic).

Warm-up is going to start with very low intensity aerobic/endurance training. Cool-down is stretching exercises and respiratory exercises (10-15 minutes).

Before and after each session blood pressure, resting HR and oxygen saturation will be measured.

Nessun intervento: Control Group
Control group participants will be asked to maintain their normal lifestyle during the 12-week period, including physical activity and social interaction patterns. Participants in the control group will undergo the same pre- and post intervention procedures at T-0 and T- 12.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Cardiorespiratory fitness
Lasso di tempo: Day 1 and after 12 weeks of the dancing or exercising intervention. Day 1 after 12 weeks for the control group participants.
Maximal Oxygen Capacity (VO2 max) is consiedered a gold standard in measuring cardiorespiratory fitness. Cardiopulmonary exercise testing will be conducted to all participants to measure cardiorespiratory fitness.
Day 1 and after 12 weeks of the dancing or exercising intervention. Day 1 after 12 weeks for the control group participants.
Quality of Life assessment
Lasso di tempo: Day 1 and after 12 weeks of the dancing or exercising intervention. Day 1 after 12 weeks for the control group participants.
Quality of life (QoL) is one of the factors that is highly impacted in the older adult population and defined as individuals' perception of their position in life in relation to their goals, expectations, standards, and concerns. Research shows that chronic heart failure (CHF) patients experience depression and sleeping disorders, resulting in poor QoL. The QoL will be measured with The Minnesota Living with Heart Failure Questionnaire (MLHFQ). Minimum value for this scale is 0 and maximum value is 105. The lower the score the better the outcome.
Day 1 and after 12 weeks of the dancing or exercising intervention. Day 1 after 12 weeks for the control group participants.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Muscle Strength
Lasso di tempo: Day 1 and after 12 weeks of the dancing or exercising intervention. Day 1 after 12 weeks for the control group participants.
All participnats will go through muscle strength measurements using hand-held dynamometers. Hand grip strength (HGS), measured with a hand-held dynamometer, is suggested as a new clinical vital sign and is recommended for use as a measurement to identify older adults at risk of poor health status. Low HGS is associated with higher rates of hospitalization, mortality, and low QoL. HGS is also identified as a physical, behavioural, and psychological factor and is proposed as a health status indicator.
Day 1 and after 12 weeks of the dancing or exercising intervention. Day 1 after 12 weeks for the control group participants.
Fall Risk Assessment
Lasso di tempo: Day 1 and after 12 weeks of the dancing or exercising intervention. Day 1 after 12 weeks for the control group participants.
Fall risk will be assessed on Biodex Balance machine.
Day 1 and after 12 weeks of the dancing or exercising intervention. Day 1 after 12 weeks for the control group participants.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

1 agosto 2026

Completamento primario (Stimato)

28 febbraio 2027

Completamento dello studio (Stimato)

31 marzo 2027

Date di iscrizione allo studio

Primo inviato

11 agosto 2026

Primo inviato che soddisfa i criteri di controllo qualità

8 settembre 2026

Primo Inserito (Effettivo)

11 settembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

11 settembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

8 settembre 2026

Ultimo verificato

1 settembre 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

Participants personal data includes full name, date of birth, age and gender, contact details and health information. This personal information will be coded and anonymised after the intervention phase of the study.

The collected anonymised data will be deleted 7 years after the publication of the results in academic sources.

The data will be available to be used for additional and subsequent research purposes within the 7 years period.

Periodo di condivisione IPD

The information will be available as soon as the data collection completed until 7 years after.

Criteri di accesso alla condivisione IPD

The Principal Investigator will have access to the collected research data. UCL Statistician will have access to the anonymised research data. PhD supervisors will be given access to the anonymised data if they request data to answer specific questions.

Tipo di informazioni di supporto alla condivisione IPD

  • STUDIO_PROTOCOLLO
  • ICF
  • RSI

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi